Bioventus Inc. (BVS) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $74.67M | +92.5% |
| 2024 | $38.80M | +152.8% |
| 2023 | $15.34M | +213.3% |
| 2022 | -$13.54M | -158.9% |
| 2021 | $22.99M | -68.0% |
| 2020 | $71.80M | +76.4% |
| 2019 | $40.71M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | $74.67M | +92.5% |
| 2024 | $38.80M | +152.8% |
| 2023 | $15.34M | +213.3% |
| 2022 | -$13.54M | -158.9% |
| 2021 | $22.99M | -68.0% |
| 2020 | $71.80M | +76.4% |
| 2019 | $40.71M | — |